92 related articles for article (PubMed ID: 17671709)
1. Expression of cyclooxygenase-2 and vascular endothelial growth factor in primary central nervous system lymphomas.
Sugita Y; Komatani H; Ohshima K; Shigemori M; Nakashima A
Oncol Rep; 2007 Sep; 18(3):617-22. PubMed ID: 17671709
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer.
Zhang XH; Huang DP; Guo GL; Chen GR; Zhang HX; Wan L; Chen SY
BMC Cancer; 2008 Jan; 8():4. PubMed ID: 18190720
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of cyclooxygenase-2 and vascular endothelial growth factor in gastrointestinal stromal tumor: possible relations to pathological parameters and clinical behavior.
Miao R; Liu N; Wang Y; Li L; Yu X; Jiang Y; Li J
Hepatogastroenterology; 2008; 55(88):2012-5. PubMed ID: 19260469
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival.
Lazăr D; Tăban S; Ardeleanu C; Simionescu C; Sporea I; Cornianu M; Vernic C
Rom J Morphol Embryol; 2008; 49(3):371-9. PubMed ID: 18758643
[TBL] [Abstract][Full Text] [Related]
5. Inducible cyclooxygenase (COX-2) in glioblastoma--clinical and immunohistochemical (COX-2-VEGF) correlations.
Buccoliero AM; Caldarella A; Gheri CF; Taddei A; Paglierani M; Pepi M; Mennonna P; Taddei GL
Clin Neuropathol; 2006; 25(2):59-66. PubMed ID: 16550738
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma.
Kolev Y; Uetake H; Iida S; Ishikawa T; Kawano T; Sugihara K
Ann Surg Oncol; 2007 Oct; 14(10):2738-47. PubMed ID: 17687613
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implication of p27 expression in primary central nervous system lymphoma.
Kunishio K; Nagao S
Brain Tumor Pathol; 2006 Oct; 23(2):77-81. PubMed ID: 18095123
[TBL] [Abstract][Full Text] [Related]
8. The clinical significance of coexpression of cyclooxygenases-2, vascular endothelial growth factors, and epidermal growth factor receptor in nasopharyngeal carcinoma.
Pan J; Kong L; Lin S; Chen G; Chen Q; Lu JJ
Laryngoscope; 2008 Nov; 118(11):1970-5. PubMed ID: 18758376
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 and vascular endothelial growth factor in ovarian endometriotic cysts and their relationship with angiogenesis.
Ceyhan ST; Onguru O; Baser I; Gunhan O
Fertil Steril; 2008 Oct; 90(4):988-93. PubMed ID: 18053993
[TBL] [Abstract][Full Text] [Related]
10. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer.
Di JM; Zhou J; Zhou XL; Gao X; Shao CQ; Pang J; Sun QP; Zhang Y; Ruan XX
Arch Med Res; 2009 May; 40(4):268-75. PubMed ID: 19608016
[TBL] [Abstract][Full Text] [Related]
12. [The potential role of Id1 in COX-2 mediated angiogenesis in gastric cancer].
Lei T; Han S; Guo XY; Ding R; Li Y; Xie HH; Bai FH; Wu KC; Ding J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(22):1570-5. PubMed ID: 17785115
[TBL] [Abstract][Full Text] [Related]
13. [The effect of cyclooxygenase-2 on lymphangiogenesis in breast cancer].
Guo GL; Yang GL; Li ZY; You J; Yang K; Huang DP; Hu XQ; Zhang XH
Zhonghua Wai Ke Za Zhi; 2008 Jan; 46(2):132-5. PubMed ID: 18509974
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
15. VEGF expression and the effect of NSAIDs on ascites cell proliferation in the hen model of ovarian cancer.
Urick ME; Giles JR; Johnson PA
Gynecol Oncol; 2008 Sep; 110(3):418-24. PubMed ID: 18606441
[TBL] [Abstract][Full Text] [Related]
16. Analysis of interleukin (IL)-8 expression in human astrocytomas: associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry.
Samaras V; Piperi C; Levidou G; Zisakis A; Kavantzas N; Themistocleous MS; Boviatsis EI; Barbatis C; Lea RW; Kalofoutis A; Korkolopoulou P
Hum Immunol; 2009 Jun; 70(6):391-7. PubMed ID: 19332096
[TBL] [Abstract][Full Text] [Related]
17. Co-expression of cyclooxygenase-2 and vascular endothelial growth factor in inflamed human pulp: an immunohistochemical study.
Güven G; Altun C; Günhan O; Gurbuz T; Basak F; Akbulut E; Cehreli ZC
J Endod; 2007 Jan; 33(1):18-20. PubMed ID: 17185121
[TBL] [Abstract][Full Text] [Related]
18. Roles of cyclooxygenase-2 in microvascular endothelial cell proliferation induced by basic fibroblast growth factor.
Qian RZ; Yue F; Zhang GP; Hou LK; Wang XH; Jin HM
Chin Med J (Engl); 2008 Dec; 121(24):2599-603. PubMed ID: 19187602
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor mRNA expression and peritumoral edema in canine primary central nervous system tumors.
Dickinson PJ; Sturges BK; Higgins RJ; Roberts BN; Leutenegger CM; Bollen AW; LeCouteur RA
Vet Pathol; 2008 Mar; 45(2):131-9. PubMed ID: 18424825
[TBL] [Abstract][Full Text] [Related]
20. Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
Nakamoto RH; Uetake H; Iida S; Kolev YV; Soumaoro LT; Takagi Y; Yasuno M; Sugihara K
Jpn J Clin Oncol; 2007 Sep; 37(9):679-85. PubMed ID: 17846040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
